AstraZeneca. Data reported to the European Medicines Agency shows Serious Neurological adverse events reported during clinical trials. 0.6% of participants were discontinued from the study due to adverse events. Cases of Transverse Myelitis, Multiple Sclerosis, Acute Demyelinating Encephalomyelitis (ADEM), Chronic Inflammatory Demyelinating Polyradiculopathy and Peripheral sensory neuropathy were also reported. Many other Neurological System Disorders were also reported.
https://www.c19vaxreactions.com/uploads/1/3/7/7/137732232/clinical_trial_reports.pdf
https://www.c19vaxreactions.com/uploads/1/3/7/7/137732232/clinical_trial_reports.pdf